MCALLISTER & QUINN, LLC

Lobbying for AURAVAX THERAPEUTICS · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Texas · Senate · posted Oct 20, 2025

Lobbying activity 3

Budget/Appropriations

Department of Defense Appropriations No Senate Bill Number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Defense

Department of Defense Appropriations No Senate Bill Number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Health Issues

Department of Defense Appropriations No Senate Bill Number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.